Skip to main content
. 2014 Feb 12;2014(2):CD003249. doi: 10.1002/14651858.CD003249.pub3

2.17. Analysis.

2.17

Comparison 2 Sublingual misoprostol versus intravenous oxytocin therapy for primary PPH treatment among women who have not received any conventional uterotonic therapy, Outcome 17 Unsatisfactory response after enrolment after enrolment.